Orthopaedic & Rheumatologic Institute Outcomes
Surgical Quality Improvement
Orthopaedic Surgery Outcomes
Orthopaedic Surgery ACS NSQIP Outcomes
January 1, 2022 – December 31, 2022
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s overall orthopaedic surgery ACS NSQIP performance benchmarked against 597 participating sites.
| Orthopaedic Surgery (597 Sites) | N | Observed | Expected |
|---|---|---|---|
| 30 Day Mortality | 643 | 0.31% | 0.44% |
| 30 Day Morbidityᵃ | 643 | 2.49% | 4.28% |
| Cardiac | 643 | 0.47% | 0.41% |
| Pneumonia | 643 | 0.31% | 0.42% |
| Unplanned Intubation | 643 | 0.31% | 0.29% |
| Ventilator > 48 Hours | 643 | 0.31% | 0.06% |
| Deep Vein Thrombosis (DVT) / Pulmonary Embolus | 643 | 1.09% | 0.85% |
| Renal Failure | 643 | 0.31% | 0.47% |
| Urinary Tract Infection (UTI) | 643 | 0.16% | 0.65% |
| Surgical Site Infection (SSI) | 643 | 0.93% | 1.77% |
| Sepsis | 642 | 0.62% | 0.47% |
| C.diff Colitis | 643 | 0.00% | 0.09% |
| Unplanned Reoperation | 643 | 1.40% | 2.33% |
| Unplanned Readmission | 643 | 5.91% | 4.66% |
American College of Surgeons National Surgical Quality Improvement Program, 2023.
ACS NSQIP® Semiannual Report July 3, 2023, Chicago: American College of Surgeons.
ᵃIdentified as a statistical outlier (lower than expected) by the ACS NSQIP hierarchical model.
